Biotricity, Inc.
BTCY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7,318 | $12,858 | $24,160 | $103,171 |
| - Cash | $365 | $786 | $570 | $12,067 |
| + Debt | $26,090 | $23,879 | $19,546 | $15,354 |
| Enterprise Value | $33,044 | $35,951 | $43,136 | $106,458 |
| Revenue | $13,790 | $12,063 | $9,639 | $7,650 |
| % Growth | 14.3% | 25.2% | 26% | – |
| Gross Profit | $10,564 | $8,356 | $5,442 | $4,570 |
| % Margin | 76.6% | 69.3% | 56.5% | 59.7% |
| EBITDA | -$3,213 | -$8,897 | -$16,070 | -$18,559 |
| % Margin | -23.3% | -73.7% | -166.7% | -242.6% |
| Net Income | -$8,421 | -$14,094 | -$18,658 | -$29,130 |
| % Margin | -61.1% | -116.8% | -193.6% | -380.8% |
| EPS Diluted | -0.55 | -1.66 | -2.26 | -3.99 |
| % Growth | 66.9% | 26.5% | 43.4% | – |
| Operating Cash Flow | -$2,380 | -$6,694 | -$13,548 | -$15,163 |
| Capital Expenditures | -$0 | $0 | -$0 | -$30 |
| Free Cash Flow | -$2,380 | -$6,694 | -$13,548 | -$15,193 |